The Board of Directors of the Company at their meeting held today have approved the Audited Standalone Financial Results for the fourth quarter and year ended on 31st March 2026 of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BDH Industries Ltd reported audited standalone financials for FY2026. Revenue from operations grew 44.3% to Rs.9,595.46 lakhs (vs Rs.6,650.83 lakhs in FY2025), driven by Pharmaceuticals segment growth. Profit after tax increased 16.6% to Rs.1,081.38 lakhs (vs Rs.927.33 lakhs). EPS stood at Rs.18.78. The Board recommended a dividend of Rs.5 per share (face value Rs.10), subject to shareholder approval at the 36th AGM on 14 August 2026. Operating cash flow turned negative at Rs.-241.05 lakhs (vs Rs.1,477.09 lakhs in prior year), largely due to a sharp rise in trade receivables (from Rs.1,418.28 to Rs.3,161.20 lakhs). Auditors CLB & Associates issued an unmodified opinion. Ms. Karthika Nair (Director retiring by rotation) and new Internal and Cost Auditors were also appointed.
Strong top-line growth and profit expansion are positive. However, the negative operating cash flow and near-doubling of trade receivables may raise concerns about working capital management and warrant monitoring. Dividend recommendation and clean audit support a stable outlook.